Ascend Laboratories, LLC is recalling 135 bottles of Aripiprazole Tablets (20 mg), a prescription medication used to treat certain mental/mood disorders. The recall was initiated because the tablets failed a spectroscopic identification laboratory test, meaning the product did not meet established quality specifications. This recall affects 500-count bottles from a single lot distributed nationwide.
The product failed an identification test, which means the chemical signature of the tablets did not match the required standards. This quality failure could potentially impact the safety or effectiveness of the medication.
You have 2 options:
Manufactured by Alkem Laboratories Ltd., INDIA; Distributed by Ascend Laboratories, LLC
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.